TIDAL THERAPEUTICS
Tidal Therapeutics is a preclinical biotech company based at LabCentral in Cambridge, MA. The company is focused on developing nanoparticles that deliver mRNA to reprogram immune cells inside the body with applications in oncology and immune diseases.
TIDAL THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
11+
Status:
Active
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Earth Vision Bio Solutions
Earth Vision Bio Solutions is a biotech company specializing in packaging products of environmentally impact plastics.
Impairment Measurement Marijuana and Driving
IMMAD is a company that specializes in the responsible use of marijuana. IMMAD technology is a tool for law enforcement use roadside.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kairos Therapeutics
Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.
Orsenix
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide.
Current Advisors List
Board_observer
2020-02-01
Current Employees Featured
Ulrik Nielsen Co-Founder, President and CEO @ Tidal Therapeutics
Co-Founder, President and CEO
2019-04-01
Founder
More informations about "Tidal Therapeutics"
Sanofi acquires Tidal Therapeutics, adding innovative mRNAbased ...
Apr 9, 2017 Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research …See details»
Sanofi acquires Tidal Therapeutics, adding innovative mRNA …
Apr 9, 2021 Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research …See details»
Sanofi buys an mRNA startup in another bet on 'off-the-shelf' cell ...
Apr 9, 2021 Sanofi on Friday agreed to acquire Tidal Therapeutics, a small, privately held, …See details»
Sanofi acquires biotech company Tidal Therapeutics for …
Mar 24, 2022 At present, Tidal Therapeutics is progressing pre-clinical programmes, including in vivo reprogramming of T cells or other immune cell types for cancer indications. Tidal Therapeutics president and CEO Ulrik …See details»
Sanofi : acquires Tidal Therapeutics, adding innovative mRNA …
Apr 9, 2021 About Tidal Therapeutics Tidal Therapeutics is a preclinical biotech company …See details»
Sanofi Acquires Tidal Therapeutics and Adds an mRNA …
Apr 14, 2021 Sanofi acquired Tidal Therapeutics for an upfront payment of $160 million and up to $310 million upon achievement of certain milestones. “We anticipate that this next generation, off-the-shelf approach has the potential to …See details»
Sanofi acquires Tidal Therapeutics - 2021-04-09 - Crunchbase
Apr 9, 2021 Tidal Therapeutics Tidal Therapeutics is a preclinical biotech company with a …See details»
Sanofi acquires Tidal Therapeutics, adding innovative mRNA …
Apr 9, 2021 PARIS, France AND CAMBRIDGE, MA, USA I April 9, 2021 I Sanofi today …See details»
Sanofi (SNY) Acquires Tidal to Aid mRNA-Based Research Platform
Apr 12, 2021 Sanofi's (SNY) acquisition of Tidal Therapeutics for $160 million is set to aid …See details»
Sanofi gains mRNA immunotherapy platform with Tidal …
Apr 12, 2021 Sanofi has acquired Cambridge, Massachusetts biotech Tidal Therapeutics: gaining its novel mRNA-based approach for in vivo reprogramming of immune cells. The value of the transaction could reach up to $470m: with …See details»
Sanofi acquires Tidal Therapeutics, adding innovative
Apr 9, 2021 PARIS AND CAMBRIDGE, MA – April 9, 2021 – Sanofi today acquired Tidal …See details»
Sanofi to Acquire Tidal Therapeutics for $470 Million - PharmTech
Sanofi announced on April 9, 2021 that it has acquired Tidal Therapeutics, a US-based pre …See details»
Sanofi acquires Tidal Therapeutics, adding innovative mRNA …
Apr 9, 2021 PARIS AND CAMBRIDGE, MA – April 9, 2021 – Sanofi today acquired Tidal …See details»
Tidal Therapeutics Company Profile 2024: Valuation, Investors ...
AbbVie Ventures, MRL Ventures Fund, Mission BioCapital, Myeloma Investment Fund, and …See details»
Sanofi pays $160M for mRNA tech to reprogram T cells in vivo
Apr 12, 2021 The biotech, LabCentral-based Tidal Therapeutics, has kept a low public profile …See details»
Sanofi acquires Tidal Therapeutics - Chemical & Engineering News
Apr 17, 2021 Sanofi has acquired the messenger RNA (mRNA) therapy start-up Tidal …See details»
Tidal Therapeutics: the benefits and leverage of the ... - LabCentral
Jun 3, 2021 What does Tidal do? Like all biotech start-ups, Tidal Therapeutics was started …See details»
Nanotech turns pro-tumor immune cells into cancer-killing triple …
Sep 5, 2019 Tidal Therapeutics is taking on the challenge of producing the nanoparticles in …See details»
Outlook Therapeutics® Streamlines Operations - Yahoo Finance
2 days ago Full NORSE EIGHT Data Readout Expected January 2025ISELIN, N.J., Dec. 13, …See details»